Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Major (ICD-10) Depression Inventory
1
x
$
0.00
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
1
x
$
30.00
Mark S. Bauer, MD: Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide
1
x
$
30.00
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
1
x
$
30.00
P. Murali Doraiswamy, MD: A Randomized Controlled Trial of Paroxetine for Noncardiac Chest Pain
1
x
$
30.00
Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist
1
x
$
30.00
The 2018 Handbook of Psychotropic Drug Interactions
1
x
$
30.00
Ross A. Baker - Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
1
x
$
30.00
Graeme F. Mason, PhD: Magnetic Resonance Spectroscopy for Studies of Neurotransmission in Vivo
1
x
$
30.00
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
1
x
$
30.00
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
1
x
$
30.00
Cornell Scale for Depression in Dementia
1
x
$
0.00
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
1
x
$
30.00
Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
1
x
$
30.00
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
1
x
$
30.00
Psychopharmacology Bulletin VOL 46 No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Clinical Global Impressions (CGI)
1
x
$
0.00
View Cart
Checkout
Home
schizophrenia
You cannot add another "Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder" to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
$
0.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
$
30.00
Add to cart
Details
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
$
30.00
Add to cart
Details
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
$
30.00
Add to cart
Details
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
$
30.00
Add to cart
Details
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
$
30.00
Add to cart
Details
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
$
30.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
$
30.00
Add to cart
Details
Exercise as a Treatment for Schizophrenia: A Review
$
30.00
Add to cart
Details
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
$
30.00
Add to cart
Details
Gender and Schizophrenia
$
30.00
Add to cart
Details
1
2
…
4
Next
Page load link
Go to Top
